TScan Therapeutics (TCRX) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for TScan Therapeutics (TCRX) over the last 4 years, with Q3 2025 value amounting to -$53.01.
- TScan Therapeutics' Times Interest Earned fell 5566.44% to -$53.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.15, marking a year-over-year decrease of 6241.75%. This contributed to the annual value of -$36.91 for FY2024, which is 4844.44% down from last year.
- According to the latest figures from Q3 2025, TScan Therapeutics' Times Interest Earned is -$53.01, which was down 5566.44% from -$56.1 recorded in Q2 2025.
- TScan Therapeutics' Times Interest Earned's 5-year high stood at -$19.13 during Q4 2022, with a 5-year trough of -$82.48 in Q3 2022.
- Over the past 4 years, TScan Therapeutics' median Times Interest Earned value was -$34.05 (recorded in 2024), while the average stood at -$39.46.
- In the last 5 years, TScan Therapeutics' Times Interest Earned surged by 6944.43% in 2023 and then crashed by 8680.62% in 2024.
- Quarter analysis of 4 years shows TScan Therapeutics' Times Interest Earned stood at -$19.13 in 2022, then tumbled by 31.05% to -$25.07 in 2023, then plummeted by 86.81% to -$46.83 in 2024, then decreased by 13.2% to -$53.01 in 2025.
- Its Times Interest Earned was -$53.01 in Q3 2025, compared to -$56.1 in Q2 2025 and -$53.39 in Q1 2025.